Consider the F-111 Aardvark. The name doesn’t exactly suggest nobility or aptitude, but it fits—thanks to the F-111’s elongated nose, which bears resemblance to the humble aardvark.

Aardvark Therapeutics, Inc. (AARD) has filed to raise $100 million in an IPO of its common stock, according to SEC S-1 registration information. The firm is a clinical-stage biopharma developing ...